Try a new search

Format these results:

Searched for:

in-biosketch:true

person:renc01

Total Results:

173


Laparoscopic adjustable gastric banding of gastric pouch from prior roux-en-y gastric bypass [Meeting Abstract]

Obeid, N R; Schwack, B F; Kurian, M S; Ren-Fielding, C J; Fielding, G A
Aims: Bariatric surgery has proven to be the most effective treatment for sustained, longterm weight loss. However, surgeons are encountering some patients with weight regain and 'weight-loss failure.' Revisional bariatric surgery is becoming more common. Our video highlights gastric banding of the gastric pouch as a feasible option for revisional surgery. Methods: The case is a 55 year-old man with morbid obesity who underwent Roux-en-Y gastric bypass 10 years prior to presentation. He suffered from significant weight regain and was again classified as morbidly obese. Workup included an upper GI series, which demonstrated a dilated gastric pouch. The patient elected to undergo gastric banding of the gastric pouch in order to provide restriction and facilitate weight loss. Operative details are illustrated. Results: The patient was discharged to home the same day and has had an uneventful recovery. Most recently, at the 4-month postoperative visit, the patient has lost 30 pounds. Conclusions: Revisional bariatric surgery is becoming more prevalent, especially for weight regain. Depending on the patient's symptoms, surgical anatomy, and preoperative workup, the 'band over bypass' technique is a feasible option for revisional surgery and is effective in managing weight regain after gastric bypass
EMBASE:71873371
ISSN: 0930-2794
CID: 1601292

Laparoscopic repair of large paraesophageal hernia with concurrent sleeve gastrectomy [Meeting Abstract]

Obeid, N R; Schwack, B F; Kurian, M S; Ren-Fielding, C J; Fielding, G A
Aims: We present an interesting case of laparoscopic repair of a giant paraesophageal hernia with simultaneous bariatric surgery. The technical aspects of this challenging operation are reviewed. The video also highlights the resulting major morbidity that can occur. Methods: A 66 year-old woman was diagnosed with a type IV paraesophageal hernia including stomach, colon, and pancreas in the left chest. She was scheduled for laparoscopic repair of the hernia defect, expressing interest in concurrent bariatric surgery. Intraoperatively, the gastroesophageal junction could not be pulled into the abdomen without significant tension. We extended the Collis gastroplasty to perform a concomitant sleeve gastrectomy. The details of the operative approach are illustrated. Results: On postoperative day 2, an esophagram revealed normal passage of contrast without leak or obstruction. However, on postoperative day 6, she became febrile, with persistent tachycardia and leukocytosis. A CT scan showed a large mediastinal fluid collection consistent with a leak. The patient was taken emergently to the OR for EGD, thoracotomy, decortication, and repair of distal esophageal perforation with muscle interposition graft. On postoperative day 7 after esophageal repair, an esophagram revealed contrast extravasation from the distal esophagus. The patient underwent a repeat thoracotomy, debridement, and esophageal resection with exclusion due to necrosis, placement of pharyngostomy tube, as well as laparotomy, gastrostomy and jejunostomy tube placement. The patient was eventually discharged to a nursing facility after a prolonged hospitalization with pulmonary and infectious complications. She required multiple readmissions for tube maintenance and infectious complications. Several months later, after nutritional optimization, she is recovering from a right thoracotomy and Roux-en-Y esophagojejunostomy. Conclusions: Large paraesophageal hernias can cause debilitating symptoms, and laparoscopic repair is often complex in nature. In morbidly obese patients, extending the Collis gastroplasty into a vertical sleeve gastrectomy can help to address the morbid obesity. However, patients must be counseled on the many serious risks and complications associated with this procedure
EMBASE:71873267
ISSN: 0930-2794
CID: 1601302

Laparoscopic revision of roux-en-y gastric bypass for recurrent, perforated marginal ulcers and anastomotic stricture [Meeting Abstract]

Obeid, N R; Schwack, B F; Kurian, M S; Ren-Fielding, C J; Fielding, G A
Aims: One of the known complications of gastric bypass is the development of marginal ulcers. Without appropriate surveillance and management, these ulcers can have severe consequences, including stricture and perforation. This video presents a patient with these complications, resulting in the need for revisional surgery. Methods: The case is a 53 year-old woman with morbid obesity who underwent Roux-en- Y gastric bypass 6.5 years ago. She developed recurrent, perforated marginal ulcers requiring operative intervention prior to her presentation. Repeat endoscopy did not reveal any residual ulcers, and preoperative esophagram showed a dilated gastric pouch. The patient underwent resection of the strictured anastomosis and recreation of the gastrojejunostomy, as highlighted in the video. Results: An esophagram on the first postoperative day showed a markedly smaller gastric pouch without leak or obstruction. The patient was able to tolerated thin liquids, and was discharged to home on postoperative day 3. At her most recent office visit 2 months postoperatively, she has recovered well and is tolerating a diet. Her current BMI is 25. Conclusions: Marginal ulceration can be seen after Roux-en-Y gastric bypass surgery, and if left untreated, can result in major morbidity including stomal stricture and gastric perforation. Laparoscopic revision of the gastrojejunostomy can be performed safely and effectively
EMBASE:71873065
ISSN: 0930-2794
CID: 1601322

Previous weight loss as a predictor of weight loss outcomes after laparoscopic adjustable gastric banding [Meeting Abstract]

Sethi, M; Beitner, M; Magrath, M; Schwack, B F; Kurian, M S; Fielding, G A; Ren-Fielding, C J
Introduction: Weight loss after laparoscopic adjustable gastric banding (LAGB) can be influenced by a variety of factors. The primary objective of this study is to investigate whether the maximum amount of previous weight loss with diet and exercise, prior to evaluation for bariatric surgery, is predictive of postoperative weight loss success among primary laparoscopic adjustable gastric banding patients. Methods: A retrospective cohort study was designed from a prospectively-collected database at a single institution. There were 999 patients who underwent primary LAGB between June 2010 and December 2011 who were considered for this study. Inclusion criteria consisted of age > 18 years, initial body mass index (BMI) > 35 kg/m2, intake information on the maximum weight loss at any time prior to referral to our bariatric practice, and at least 2 years of postoperative follow-up. Patients with prior bariatric surgery and patients without a recorded maximum previous weight loss were excluded. Data obtained included preoperative demographics, BMI, comorbidities, maximum amount of previous weight loss, and number of previous weight loss attempts, as well as postoperative weight (lbs), BMI, and percent excess weight loss (%EWL), at 12, 18, and 24 months postoperatively. The primary outcomes were mean %EWL, percent that achieve weight loss success (%EWL > 40), and percent with suboptimal weight loss (%EWL<20) at 2 years post-LAGB. Statistical analysis was performed using SAS, with tests including chi-square, ANOVA, linear and logistic regression. Results: Of the 999 patients, 462 primary LAGB patients met criteria. Mean previous weight loss was 29.7 lbs (SD = 27.6, range = [0,175]). These patients were divided into four previous weight loss groups (0 lbs, 1-20 lbs, 21-50 lbs, > 50 lbs) for analysis. Baseline patient characteristics between the four groups demonstrated that patients with the greatest previous weight loss (> 50 lbs) were more likely to be male (p = 0.01) and had higher baseline weight/BMI (p<0.0001). There were no differences in comorbidity or operative time between the groups. In order to account for the baseline differences between the four previous weight loss groups, an adjusted model was used for analysis, controlling for age, gender, baseline BMI, and band type. In the adjusted model, those with > 50 lbs of previous weight loss had 8.8 % EWL, 6.7 % EWL, and 5.0 % EWL more than those with 0, 1-20, and 21-50 lbs of previous weight loss, respectively (p<0.0001) [Table 1]. Patients with > 50 lbs of previous weight loss were more likely to achieve weight loss success (> 40 % EWL) at 2 years post-LAGB (p = 0.047), and were less likely to have suboptimal weight loss (<20 % EWL) at 2 years post-LAGB (p = 0.027). Conclusion: Previous weight loss is a significant predictor of weight loss after LAGB. With multiple options for weight loss surgery, this study helps elucidate which patients may be more likely to achieve greater weight loss with the LAGB, allowing clinicians to appropriately counsel patients preoperatively. (Table Presented)
EMBASE:71872063
ISSN: 0930-2794
CID: 1601342

Intraoperative leak testing has no correlation with leak after laparoscopic sleeve gastrectomy [Meeting Abstract]

Sethi, M; Zagzag, J; Patel, K; Magrath, M; Parikh, M S; Saunders, J K; Ude-Welcome, A O; Schwack, B F; Kurian, M S; Fielding, G A; Ren-Fielding, C J
Introduction: Staple line leak is the most feared complication after sleeve gastrectomy. Intraoperative methylene blue and air leak tests are routinely used to evaluate for leak, however the utility of these tests is controversial. The 2012 International Sleeve Gastrectomy Expert Panel failed to reach a consensus about whether routine intraoperative leak tests should be performed. Additionally, these tests are not benign - they introduce increased instrumentation, with reports of nasogastric tubes causing esophageal perforation, as well as increased costs in the form of resource utilization. We hypothesize that the practice of routine intraoperative leak testing is unnecessary during sleeve gastrectomy. Methods and Procedures: A retrospective cohort study was designed using a prospectively-collected database of seven bariatric surgeons from two institutions. 1,257 consecutive patients who underwent sleeve gastrectomies between March 2012 and June 2014 were included. The performance of intraoperative leak testing and the type of test (air or methylene blue) were based on surgeon preference. Data obtained included BMI, patient demographics, comorbidity, presence or absence of intraoperative leak test, result of leak test, and type of test. The primary outcome was leak rate between the leak test (LT) group and the non-leak test (NLT) group. SPSS-22 was used for univariate and multivariate analyses. Results: Of the 1,257 sleeve gastrectomy cases, most (99.68 %) were laparoscopic, except for two (0.16 %) open and two (0.16 %) converted cases. 1,164 (92.6 %) patients had routine intraoperative leak tests performed; there were no positive intraoperative leak tests in the entire cohort. 93 patients (7.4 %) did not have intraoperative leak tests performed. Thirteen (1 %) patients developed staple line leaks, with no difference in leak rate between the LT and NLT groups (1 % vs. 1.1 %, p = 1.000). There were some baseline differences between the groups, however (Table 1). After adjusting for these differences and other possible confounders with binary logistic regression, the observed lack of association between leak and intraoperative leak test remained. In this cohort, leaks presented at a mean of 11.3 days postoperatively (range = [1,35]), with only two leaks presenting during the index admission. Of those two, one patient with a leak seen on postoperative day 1 esophagram underwent a repeat leak test during diagnostic laparoscopy, which was negative. Despite suture reinforcement, the leak persisted and the patient eventually required conversion to gastric bypass. Conclusion: Intraoperative leak testing has no correlation with postoperative leak occurrence after laparoscopic sleeve gastrectomy and is not predictive of the later development of staple line leak. (Table Presented)
EMBASE:71871568
ISSN: 0930-2794
CID: 1601352

Surgical management and outcomes of patients with marginal ulcer after Roux-en-Y gastric bypass

Chau, Edward; Youn, Heekoung; Ren-Fielding, Christine J; Fielding, George A; Schwack, Bradley F; Kurian, Marina S
BACKGROUND: Marginal ulcers (MUs) are potentially complex complications after Roux-en-Y gastric bypass. Although most resolve with medical management, some require surgical intervention. Many surgical options exist, but there is no standardized approach, and few reports of outcomes have been documented in the literature. The objective of this study was to determine the outcomes of surgical management of marginal ulcers. METHODS: Data from all patients who underwent surgical intervention between 2004 and 2012 for treatment of MU after previous Roux-en-Y gastric bypass were reviewed. RESULTS: Twelve patients with MUs underwent reoperation. Nine patients had associated gastrogastric fistulae (75%). The median time to reoperation was 43 months. Ten patients underwent subtotal gastrectomy, of which 9 had a revision of the gastrojejunal anastomosis and 1 did not. One underwent total gastrectomy with esophagojejunal anastomosis for ulcer after previous revisional partial gastrectomy, and 1 patient underwent video-assisted thoracoscopic truncal vagotomy for persistent ulcer-related bleeding in the early postoperative period. Three patients (25%) experienced postoperative complications associated with revisional surgery requiring reoperation. At median follow-up time of 35 months, 7 patients (58%) had chronic abdominal pain, and 4 patients (33%) had intermittent diarrhea. Three patients (25%) were lost to recent follow-up. None had recurrence of MU. CONCLUSION: Patients can undergo one of several available surgical interventions, including laparoscopic subtotal gastrectomy with gastrojejunostomy revision. Though this appears to offer definitive treatment of MU, its benefits must be weighed against the increased risk of significant postoperative complications and chronic symptoms related to revisional surgery.
PMID: 25868835
ISSN: 1878-7533
CID: 1532832

Safety of laparoscopic adjustable gastric banding with concurrent cholecystectomy for symptomatic cholelithiasis

Obeid, Nabeel R; Kurian, Marina S; Ren-Fielding, Christine J; Fielding, George A; Schwack, Bradley F
BACKGROUND: The prevalence of cholelithiasis correlates with obesity. Patients often present for bariatric surgery with symptomatic cholelithiasis. There is a concern of cross-contamination when performing laparoscopic adjustable gastric banding (LAGB) with concurrent cholecystectomy. The primary goal of this study is to address the safety and feasibility of this practice. METHODS: A retrospective cohort study was designed from a prospectively collected database. All LAGB patients from July 2005 to April 2013 were included. Patients undergoing LAGB with concurrent cholecystectomy comprised the study group (LAGB/chole). The control group (LAGB) consisted of patients undergoing LAGB alone, and was selected using a 3:1 (control:study) case-match based on demographic and comorbidity data. The primary outcome was overall complication rate, with secondary outcomes including operating room (OR) time, length of stay (LOS), 30-day readmission/reoperation, erosion, infection, and band/port revisional surgery. RESULTS: There were 4,982 patients who met criteria. Of these, 28 patients had a LAGB with concurrent cholecystectomy, comprising the LAGB/chole (study) group. The remaining 4,954 patients were eligible controls, of which 84 were selected for the LAGB (control) group. Demographic and comorbidity data, along with mean follow-up time, were similar between the two groups. OR time was longer in the LAGB/chole group, but LOS was the same. The overall complication rate in the LAGB/chole group was 21 (n = 6) versus 20 % (n = 17) in the LAGB group (p = 0.893). Thirty-day readmission and reoperation were similar. There was also no difference in port site, wound, and intra-abdominal infections. There were no band erosions in either group. CONCLUSIONS: Performing a concurrent cholecystectomy at the time of LAGB does not result in increased immediate or delayed morbidity. Although longer to perform, this safe operation would avoid a second surgery for a patient already diagnosed with symptomatic cholelithiasis.
PMID: 25159640
ISSN: 0930-2794
CID: 1162422

Reduction of Knee Osteoarthritis Symptoms in a Cohort of Bariatric Surgery Patients. [Meeting Abstract]

Leyton-Mange, Andrea; Lin, Janice; Flanagan, Ryan; Wilder, Evan; Bhatia, Jay; Taufiq, Farah; Browne, Lauren; Attur, Mukundan; Vieira, Renata La Rocca; Parikh, Manish; Ren-Fielding, Christine; Abramson, Steven B; Samuels, Jonathan
ISI:000344384904392
ISSN: 2326-5205
CID: 2331232

Laparoscopic gastric banding resolves the metabolic syndrome and improves lipid profile over five years in obese patients with body mass index 30-40 kg/m

Heffron, Sean P; Singh, Amita; Zagzag, Jonathan; Youn, Heekoung A; Underberg, James A; Fielding, George A; Ren-Fielding, Christine J
BACKGROUND: Obesity, metabolic syndrome (MS) and dyslipidemia are independent risk factors for cardiovascular disease. Bariatric surgery is increasingly recognized as an effective intervention for improving each of these risk factors. There are sparse data on the long-term durability of metabolic changes associated with bariatric surgery, in particular with laparoscopic gastric banding (LGB). Our objective was to evaluate the durability of metabolic changes associated with LGB in nonmorbid obesity. METHODS: Fifty obese patients (BMI 30-40) with >/=1 obesity-related comorbidity were prospectively followed for five years. At follow-up, subjects underwent fasting blood measures, including lipid NMR spectroscopy and standard lipid profile. RESULTS: Forty-seven patients (45 female, mean age 43.8 years) completed four years follow-up (46 completed five years). Baseline BMI was 35.1 +/- 2.6. Subjects exhibited mean weight loss of 22.3 +/- 7.9 kg (22.9 +/- 7.4%) at year one and maintained this (19.8 +/- 10.2%) over five years. At baseline, 43% (20/47) of subjects met criteria for MS. This was reduced to 15% (7/47) at year one and remained reduced over five years (13%, 6/46) (p < 0.001). There were reductions in triglycerides (p < 0.001) and increases in HDL cholesterol (HDL-C, p < 0.001) and HDL particle concentration (p = 0.02), with a trend toward increased HDL particle size (p = 0.06) at year five. Changes in triglycerides and HDL-C were more prominent in patients with MS at baseline, but unassociated with weight loss or waist circumference. Changes in HDL particle size and concentration were not associated with MS status, weight loss, waist circumference, or statin use. CONCLUSIONS: LGB produces significant weight loss, resolution of MS and changes in lipid profile suggestive of beneficial HDL remodeling. These changes persist five years following LGB.
PMID: 25240114
ISSN: 0021-9150
CID: 1259062

Single-stage versus 2-stage sleeve gastrectomy as a conversion after failed adjustable gastric banding: 30-day outcomes

Obeid, Nabeel R; Schwack, Bradley F; Kurian, Marina S; Ren-Fielding, Christine J; Fielding, George A
BACKGROUND: Sleeve gastrectomy (SG) is being performed as a conversion after adjustable gastric banding (AGB), often in a single stage. However, some argue that it should be performed in 2 stages to improve safety. Few studies compare complications between 1-stage and 2-stage procedures. Our aim is to compare the 30-day complication rates among these two groups. METHODS: We retrospectively reviewed patients converted from AGB to SG between 8/2008 and 10/2013 and compared patients undergoing 1-stage and 2-stage techniques. Primary outcome was overall 30-day adverse event rate (postoperative complication, readmission, or reoperation). Secondary outcomes included operating room (OR) time, length of stay (LOS), leak, infection, and bleeding rates, as well as mortality. RESULTS: A total of 83 patients underwent SG after band removal; three were excluded due to short follow-up, leaving 60 1-stage and 20 2-stage. Mean time from band removal to SG for 2-stage was 438 days. Demographics, intraoperative technique (bougie size, staple reinforcement, oversewing staple line, and leak test), and mean follow-up were not statistically different. Mean OR time (132.1 min 1-stage vs. 127.8 min 2-stage, p = 0.702) and LOS (3.1 vs. 2.4 days, p = 0.676) were similar. Overall 30-day adverse event rate was 12 % for 1-stage versus 15 % for 2-stage procedures (p = 0.705). Differences in 30-day readmission (8 vs. 5 %) and reoperation (5 vs. 0 %) were not statistically significant (p = 0.999 and 0.569, respectively). Leak (3 vs. 0 %, p = 0.999), abscess (2 vs. 5 %, p = 0.440), and bleeding rates (2 vs. 0 %, p = 0.999) were not different. There were no deaths. CONCLUSIONS: SG performed as a conversion after AGB is safe and feasible. Our findings indicate no statistical difference in 30-day outcomes when performed in 1 or 2 stages. Future studies with larger sample sizes are necessary to further investigate these differences.
PMID: 24902818
ISSN: 0930-2794
CID: 1033302